As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...